A human Dravet syndrome model from patient induced pluripotent stem cells.
about
Functional Properties of Human Stem Cell-Derived Neurons in Health and DiseasehiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineUsing Patient-Derived Induced Pluripotent Stem Cells to Model and Treat EpilepsiesImportance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neuronsGenetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental modelsNew insights into the generation and role of de novo mutations in health and diseaseUtility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological DisordersConcise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem CellsSCN8A encephalopathy: Research progress and prospectsAll-optical electrophysiology in mammalian neurons using engineered microbial rhodopsinsImpaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndromeStem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Modeling human neurological disorders with induced pluripotent stem cells.Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathyConnectivity and circuitry in a dish versus in a brainProbing disorders of the nervous system using reprogramming approaches.Reprogramming patient-derived cells to study the epilepsiesModel systems for studying cellular mechanisms of SCN1A-related epilepsy.A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.iPS cell technologies: significance and applications to CNS regeneration and disease.Regenerative medicine for epilepsy: from basic research to clinical application.Induced pluripotent stem cells for modeling of pediatric neurological disorders.The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes.I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.Models for discovery of targeted therapy in genetic epileptic encephalopathies.Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.Opposing Phenotypes in Dravet Syndrome Patient-Derived Induced Pluripotent Stem Cell Neurons: Can Everyone Be Right?Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.Translating regenerative medicine techniques for the treatment of epilepsy
P2860
Q26747622-DE54D8FC-2905-404D-AACA-01B5C6621C80Q26751506-EAC9F0BE-9DFC-4C3E-AF41-615B70B11B37Q26796332-4DB5F2F2-984C-4A19-A916-AE8103C3375EQ26799285-A02084E7-FCDF-47FC-96B0-490E72F43B60Q26861471-5916D0D0-EA1F-49C2-82C8-E2916053226CQ28073446-2CF1A89B-8285-4E00-9106-5EE8B86BB01BQ28080219-C0591795-0020-4726-B903-8C2168A20AC2Q28081651-C15294D5-CCA9-4DBD-81A3-745FDD19E211Q33866136-118CE495-942A-4DC6-82EE-D42F3D2112C8Q33983852-4A678954-05DB-4F5C-9267-42417FF98515Q34002328-1E3C498E-DC07-4C76-BEFC-2A76CFDE8161Q34845881-C3831B38-8380-4B08-B005-789594AE5A3EQ35056065-982CE3A0-BD66-4424-8254-705CE54FC258Q35597578-86882606-2F76-4FFD-84FE-A24AAF51A708Q35684598-69C31546-6342-4D2B-8203-27C8EC87EBCFQ35761135-20974374-2E5E-4724-AA92-B67CF93C4C55Q35789597-7864A7E3-BA2F-40EC-BDF7-BA270E2FE642Q36760270-EC257007-2409-44A7-ADCE-F1DB9C8F0925Q37127359-22CA9B67-8B93-4AC5-8E21-DB48BF78C41BQ37688424-809D39E5-76DB-40DA-BF2A-CA588BA16EDAQ38167275-ACC70343-EAAE-4866-AEEC-9ED02216B147Q38212628-0DA584FD-0461-4AEC-8181-1DC6AEC6FF5AQ38349063-2BE39396-78A4-4D5F-992C-536303175949Q38820880-CD079DFB-28D8-40AB-A299-8CF7DDEAFF6CQ38865951-CDBF066A-AFB3-402F-AA06-20BCEABD3D05Q39457643-9FFBC47A-70BB-4DA3-B8D9-AC2E42DEC2D5Q41808396-66D55BB6-418D-4B52-8630-AE29E0F83532Q47132023-F6EC11CF-3317-428B-BADA-C8FF0F2AE784Q47269323-EBAEA613-475E-4F5F-BABA-C42F9DF9AF5CQ48931004-474843C1-AA7E-4AD2-961F-4DBDB33DB66EQ55471525-D37430ED-7A80-4504-AC92-D601EA256376Q57153018-E3C47E81-3DD7-4809-8F16-EA10988B26DA
P2860
A human Dravet syndrome model from patient induced pluripotent stem cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A human Dravet syndrome model from patient induced pluripotent stem cells.
@en
type
label
A human Dravet syndrome model from patient induced pluripotent stem cells.
@en
prefLabel
A human Dravet syndrome model from patient induced pluripotent stem cells.
@en
P2093
P2860
P921
P356
P1433
P1476
A human Dravet syndrome model from patient induced pluripotent stem cells.
@en
P2093
Christoph Lossin
Kazuki Nabeshima
Masayuki X Mori
Norimichi Higurashi
Shinichi Hirose
Shutaro Katsurabayashi
Taku Uchida
Wado Akamatsu
Yohei Okada
P2860
P2888
P356
10.1186/1756-6606-6-19
P577
2013-05-02T00:00:00Z
P5875
P6179
1025386517